Error 404 - Not Found

Suggestions

Bextra Stroke - Defective Drug Information Apr 7, 2005 any plans to recall their defective drug or strengthen warning labels. In response to Bextra stroke and heart attack risks, the FDA After comprehensive investigation , the FDA determined that Bextra stroke, FAQ on Bextra , including side effects, warnings and drug information from the FDA .

FDA Warns on Painkillers; Drug Pulled - Los Angeles Times A congressional investigation last year revealed that the FDA had downplayed and Bextra should be available on the market, albeit with black-box warnings . February: An FDA panel concluded Vioxx, Celebrex and Bextra posed heart

Why Was Orudis Discontinued? | eHow.com The risk of NSAID litigation was clearly rising in the wake of the Vioxx and Bextra withdrawals and FDA warning requirements on packaging about CV's as a

Pfizer's Off-Label Bextra Team Was Called "The Highlanders" | BNET Jun 26, 2009 Previous BNET coverage of Bextra : Pfizer Exec: Company Approved of billion to resolve federal criminal and civil health-care fraud investigations . FDA Issues Rare Quadruple Warning to Kidney Drug Maker; Next Up,

FDA : Pfizer Ignored Warnings , Gets Record Fine Bextra , one of a class of painkillers known as COX-2 inhibitors, the past but are proud of the action we've taken to strengthen our internal controls and Department resolved the investigation into promotion of all those drugs,

NSAIDS Stevens-Johnson Syndrome law firm in SJS toxic tort & law FDA , PHARMACIA UPDATE BEXTRA LABEL WITH NEW WARNINGS He called for a congressional investigation of the Vioxx approval process and the relationship between Merck and the Food and Drug FDA Promises To Strengthen Drug Reviews

Pfizer fined $2.3 billion for illegal marketing in off-label drug Sep 2, 2009 At the FDA's request, Pfizer pulled Bextra off the market in April but the lawsuits were sealed and the investigation ongoing at the time, taken to strengthen our internal controls and pioneer new procedures."

Vioxx Bextra Celebrex Cox-II Inhibitors Blood Clot Injury Attorney The warning comes after several investigative reports by The Associated FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)

Alerts In addition,the revised label strengthens the warnings about the risk of . Based on these reports, FDA has approved labeling changes for Bextra that

Celebrex Stroke - Online Lawyer Source At the same time the Bextra recall was ordered, the FDA also ordered Pfizer to strengthen its warnings about Celebrex stroke and heart attack risks on all